PET/CT for Inflammatory Diseases

This comprehensive guide sheds new light on the benefits of FDG PET/CT  in diagnosing inflammatory diseases. Although FDG PET/CT offers an invaluable tool for diagnosing inflammatory diseases, the clinical evidence on its application remains limited.

To remedy this gap, each chapter of this book includes detailed descriptions of how FDG PET/CT can be used in connection with a specific inflammatory disease. Further, the authors discusses the precise clinical presentation, including key images and their interpretation, techniques and diagnosis. As such, it allows readers to see for themselves how valuable FDG PET/CT is for the diagnosis of cardiac sarcoidosis and aortitis syndrome, as well as rheumatic diseases and neuroimflammation, and the detection of the disease focus of inflammation or fever of unknown origin.

• Neuroinflammation
• Sarcoidosis
• Rheumatoid arthritis
• Collagen disease
• Malignant lymphoma
• Aortitis syndrome
• Diagnostic Radiology
• Cardiography

“A collection of richly illustrated didactic cases, including key images and their interpretation, techniques, and diagnosis … . Each chapter is complemented by a review of the recent literature. The usefulness of the book may be found mainly in stimulating a greater diffusion of nuclear medical methods … . in addition to professionals and residents in Diagnostic Imaging, this volume can be of great interest to clinicians who have in their daily experience the diagnosis and treatment of inflammatory diseases.” (Pasqualina Sannino and Luigi Mansi, European Journal of Nuclear Medicine and Molecular Imaging, Vol. 48, 2021)

“It is a high-quality textbook written with the cooperation of many doctors and researchers in Japan and China who are active in the field of nuclear medicine. This book will serve as a valuable reference in clinical practice and research for many nuclear medicine physicians and researchers, and I recommend keeping this book on hand as a ready source of information.” (Kengo Ito, Annals of Nuclear Medicine, Vol. 34, 2020)

• Department of Radiology, Fujita Health University, Toyoake, Japan

  Hiroshi Toyama

• Department of Nuclear Medicine, The First Hospital of China Medical University, Shenyang, China

  Yaming Li

• Joint Research Division for the Quantum Cancer Therapy, Research Center for Nuclear Physics, Professor Emeritus, Osaka University, Suita, Japan

  Jun Hatazawa

• Shanghai University of Medicine & Health Sciences, Shanghai, China

  Guang Huang

• Department of Radiology, Southern TOHOKU General Hospital, Koriyama, Japan

  Kazuo Kubota

Hiroshi Toyama, M.D., Ph.D.,

Department of Radiology,

Fujita Health University

Toyoake, Aichi, Japan

 htoyama@fujita-hu.ac.jp

Yaming Li, M.D., Ph.D.,

Department of Nuclear Medicine 

The First Hospital of China Medical University

Shenyang, Liaoning, China

Jun Hatazawa, M.D., Ph.D.,

Specially Appointed Professor,

Joint Research Division for the Quantum Cancer Therapy, Research

Center for Nuclear Physics Osaka University

Suita, Osaka, Japan

hatazawa@tracer.med.osaka-u.ac.jp

Guang Huang, M.D., Ph.D.,

Shanghai, China

huang2802@163.com

Kazuo Kubota, M.D., Ph.D.,

Department of Radiology,

Koriyama, Fukushima, Japan

kkubota@cpost.plala.or.jp

Policies and ethics